Australia's Memphasys advances on order wins in the Middle East

Memphasys

27/05/2026 05:13

** Shares of Memphasys MEM.AX rise 25% to A$0.005 in early trade, on track for their biggest single-session rise since early February
** Reproductive biotech firm says its exclusive Middle East and North Africa commercialisation partner has placed an order for 1000 Felix cartridges
** Felix system is a bio-separation technology that isolates the most viable sperm cells for human-assisted reproduction
** Co says order includes 400 cartridges from Qatar, UAE and Kuwait, with further 600 confirmed for October this year from existing clients
** More than 6.2 million shares change hands, 3 times the 30-day average
** Stock down 28.6% YTD, including the day's moves

 (Reporting by Nikita Maria Jino in Bengaluru)
 ((Nikita.Jino@thomsonreuters.com;))